About 50 results
Open links in new tab
  1. Hepatic soluble epoxide hydrolase activity regulates cerebral Aβ ...

    Aug 2, 2023 · Soluble epoxide hydrolase (sEH) is expressed in both peripheral tissues and CNS. Its upregulation has been implicated in multiple neurological conditions, including depression, …

  2. Epoxide Hydrolase, a Fat New Target for Alzheimer’s Therapy?

    Dec 15, 2020 · Given that epoxide hydrolase inhibitors are already being tested in the clinic for other conditions, they may have the potential to become a new class of AD drug. Darryl Zeldin, National …

  3. Soluble epoxide hydrolase: a next-generation drug target for Alzheimer ...

    Gregory A, Tang C, Fan F. Soluble epoxide hydrolase: a next-generation drug target for Alzheimer's disease and related dementias. Neural Regen Res. 2025 Sep 1;20 (9):2585-2586.

  4. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse ...

    Dec 15, 2020 · Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep. 2018 Mar 27;8 (1):5279. PubMed. O'Brien CE, Santos PT, Kulikowicz E, Lee JK, …

  5. Could Inhibiting a Liver Enzyme Ameliorate Alzheimer’s ... - ALZFORUM

    Aug 2, 2023 · But what if targeting a peripheral enzyme could do the job? In the June 26 Neuron online, researchers led by Xin-Hong Zhu at Shenzhen University, China, reported that inhibiting a liver …

  6. Genetic deletion of soluble epoxide hydrolase delays the progression …

    Lee HT, Lee KI, Chen CH, Lee TS. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease. J Neuroinflammation. 2019 Dec 17;16 (1):267. PubMed.

  7. C9orf72-associated neurodegeneration in ALS-FTD: breaking new …

    Herrmann D, Parlato R. C9orf72-associated neurodegeneration in ALS-FTD: breaking new ground in ribosomal RNA and nucleolar dysfunction. Cell Tissue Res. 2018 Aug;373 (2):351-360. Epub 2018 …

  8. www.alzforum.org

    www.alzforum.org

  9. DNL919 - ALZFORUM

    Background This TREM2 agonist antibody activates microglia to phagocytose amyloid. DNL919 contains a transferrin-receptor binding sequence engineered into its Fc domain. Thus, the antibody binds to …

  10. New Therapeutic Strategy—Mimic the ApoE Christchurch Mutation?

    Oct 24, 2023 · Further, a recent study showed that inhibition of liver enzyme soluble epoxide hydrolase drives a subsequent increase of 14,15-epoxyeicosatrienoic acid in the blood and into the brain, …